Startup based in the United States, most recent round Seed.
Cellens Inc is a startup based in the United States. Its most recent tracked round is Seed.
Cellens Inc develops a noninvasive, urine-based cancer diagnostics platform using nanoscale biophysical markers and machine learning to accurately detect bladder cancer and potentially other cancer types from bodily fluids.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.